Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years

This is a year-long study evaluating the efficacy of both daily and intermittent treatment of asthma in children who experience symptoms episodically (i.e., seasonally, usually in the context of upper respiratory tract infection).

Inclusion Criteria:

• Patients aged 6 months to 5 years with episodic (periodic) asthma

Exclusion Criteria:

• Patients who are not in otherwise good health
• Patients who have persistent asthma (continual asthma symptoms)